An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. | J Pharmacol Exp Ther;297(3): 1122-8, 2001 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.

Nakase, H; Okazaki, K; Tabata, Y; Uose, S; Ohana, M; Uchida, K; Nishi, T; Debreceni, A; Itoh, T; Kawanami, C; Iwano, M; Ikada, Y; Chiba, T.

Affiliation

Nakase H; Division of Gastroenterology and Endoscopic Medicine, and Institute for Frontier Medical Science, Kyoto University, Kyoto, Japan.

J Pharmacol Exp Ther ; 297(3): 1122-8, 2001 Jun.

Article in En | MEDLINE | ID: mdl-11356937

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Dexamethasone / Drug Delivery Systems / Colitis / Intestinal Mucosa Type of study: Prognostic_studies Language: En Journal: J Pharmacol Exp Ther Year: 2001 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Dexamethasone / Drug Delivery Systems / Colitis / Intestinal Mucosa Type of study: Prognostic_studies Language: En Journal: J Pharmacol Exp Ther Year: 2001 Document type: Article Affiliation country: